miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

被引:57
作者
Crippa, Elisabetta [1 ,2 ]
Lusa, Lara [1 ,2 ,3 ]
De Cecco, Loris [1 ,2 ]
Marchesi, Edoardo [1 ,2 ]
Calin, George Adrian [4 ,5 ]
Radice, Paolo [1 ,2 ]
Manoukian, Siranoush [6 ]
Peissel, Bernard [6 ]
Daidone, Maria Grazia [1 ]
Gariboldi, Manuela [1 ,2 ]
Pierotti, Marco Alessandro [7 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy
[2] Fdn Ist FIRC Oncol Mol, Milan, Italy
[3] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA
[6] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy
[7] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy
关键词
ESTROGEN-RECEPTOR-ALPHA; MESSENGER-RNA; GENETIC SUSCEPTIBILITY; MICRORNA SIGNATURES; PROTEINS; DIFFERENTIATION; GLIOBLASTOMA; INHIBITOR; TAMOXIFEN; GENOMICS;
D O I
10.1371/journal.pone.0087039
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its "in silico" predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class.
引用
收藏
页数:12
相关论文
共 48 条
[1]   Update on genetic predisposition to breast cancer [J].
Ahmed, Munaza ;
Lalloo, Fiona ;
Evans, D. Gareth .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (08) :1103-1113
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]   Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach [J].
Beger, C ;
Pierce, LN ;
Krüger, M ;
Marcusson, EG ;
Robbins, JM ;
Welcsh, P ;
Welch, PJ ;
Welte, K ;
King, MC ;
Barber, JR ;
Wong-Staal, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :130-135
[4]   MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype [J].
Blenkiron, Cherie ;
Goldstein, Leonard D. ;
Thorne, Natalie P. ;
Spiteri, Inmaculada ;
Chin, Suet-Feung ;
Dunning, Mark J. ;
Barbosa-Morais, Nuno L. ;
Teschendorff, Andrew E. ;
Green, Andrew R. ;
Ellis, Ian O. ;
Tavare, Simon ;
Caldas, Carlos ;
Miska, Eric A. .
GENOME BIOLOGY, 2007, 8 (10)
[5]   Genetic susceptibility to breast cancer [J].
Bradbury, Angela R. ;
Olopade, Olufunmilayo I. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2007, 8 (03) :255-267
[6]   microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer [J].
Buffa, Francesca M. ;
Camps, Carme ;
Winchester, Laura ;
Snell, Cameron E. ;
Gee, Harriet E. ;
Sheldon, Helen ;
Taylor, Marian ;
Harris, Adrian L. ;
Ragoussis, Jiannis .
CANCER RESEARCH, 2011, 71 (17) :5635-5645
[7]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[8]   Downregulation of miR-342 is associated with tamoxifen resistant breast tumors [J].
Cittelly, Diana M. ;
Das, Partha M. ;
Spoelstra, Nicole S. ;
Edgerton, Susan M. ;
Richer, Jennifer K. ;
Thor, Ann D. ;
Jones, Frank E. .
MOLECULAR CANCER, 2010, 9
[9]   Pathology of hereditary breast cancer [J].
Da Silva, Leonard ;
Lakhani, Sunil R. .
MODERN PATHOLOGY, 2010, 23 :S46-S51
[10]   Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma [J].
de Candia, Paola ;
Akram, Muzaffar ;
Benezra, Robert ;
Brogi, Edi .
HUMAN PATHOLOGY, 2006, 37 (08) :1032-1041